A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population
Clinical trial NCT00700193 · COMPLETED
Trial details
- NCT number
- NCT00700193
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2006-06-01
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.